Gamidor Diagnostics
Gamidor Diagnostics is an Israeli medical diagnostic distributor founded in 1984, exclusively representing global manufacturers including Revvity, Thermo Scientific, and Tecan. It supplies hospitals, HMOs, and laboratories across Israel with diagnostic systems, reagents, and proprietary genetic screening tests.
- Company typePrivate
- Founded1984
- HeadquartersPetah Tiqwa, Israel
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Gamidor Diagnostics does
Gamidor Diagnostics is an Israeli medical diagnostic distribution company founded in 1984 by Mr. Yacob Ofer and the Gamida for Life Group, headquartered in Petah Tikva, Israel. The company serves as the exclusive Israeli representative for multiple leading international diagnostic manufacturers, including Revvity, Thermo Scientific/Phadia, Tecan, Snibe, and Roche/VENTANA, distributing systems, reagents, and services to clinical laboratories, hospitals, health maintenance organizations (HMOs), academic research institutes, and the general public across Israel.
The product portfolio spans genetics (MyScreen NGS-based carrier screening covering 289–500+ diseases, Vanadis NIPT, NanoChip microarray, AutoDelfia prenatal screening), allergy and autoimmunity (Phadia ImmunoCAP and EliA tests), tissue diagnostics (VENTANA/Roche), central laboratory diagnostics (Snibe CLIA analyzers deployed in 50+ facilities), point-of-care testing (HemoScreen, NanoDx TBI, rapid tests), molecular biology, and life science automation. Proprietary products include MyScreen, an NGS-based extended carrier screening test designed for the Israeli population, and GeneFax, an AI-powered genetic counseling chatbot co-developed with Optra Health. The company holds ISO 9001:2015, ISO 27799:2016, and ISO 27001:2022 certifications.
Gamidor's revenue model combines distribution-based sales of diagnostic systems and reagents with recurring testing services. Snibe analyzers deployed across Israeli hospitals perform tens of millions of tests annually, indicating volume-based recurring reagent revenue. Genetic testing is conducted both privately and through the Israeli health basket; notably, MyScreen entered the state-funded health basket in November 2024, covering 289 diseases across all Israeli populations through the four major HMOs. Distribution is direct via field sales teams to hospital laboratories, HMO central laboratories, the Ministry of Health, and academic research institutions. The company has over 100 professional employees and is privately held without institutional investment or public listing.
Gamidor Diagnostics firmographics
Firmographics- Name
- Gamidor Diagnostics
- Legal name
- גאמידור דיאגנוסטיקה (1984) בע"מ
- Website
- https://gamidor.co.il
- Company type
- Private
- Founded year
- 1984
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Gamidor Diagnostics is an Israeli medical diagnostic distributor founded in 1984, exclusively representing global manufacturers including Revvity, Thermo Scientific, and Tecan. It supplies hospitals, HMOs, and laboratories across Israel with diagnostic systems, reagents, and proprietary genetic screening tests.
- Ownership category
- akta.pro rank
Gamidor Diagnostics industry classification
Industry- Product category
- In-Vitro Diagnostics Distribution
- NAICS
- Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)
- akta.pro secondary industries
- Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Genetic & Prenatal Testing Laboratories (HLAFAMAH), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD)
Keywords
Where Gamidor Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Petah Tiqwa
- HQ country
- Israel
- HQ region
- Middle East
Offices2 records
Markets served
Gamidor Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Diagnostic Systems and Reagents Distribution: Distributes diagnostic systems, reagents and services to clinical laboratories, hospitals, HMOs, and research institutes. Revenue generated through exclusive distribution agreements with international manufacturers including Revvity, Thermo Scientific, Tecan, and others.
- Genetic Testing Services: Provides genetic screening tests including MyScreen (NGS-based carrier screening), NIPT, prenatal screening, and neonatal screening. Tests are performed in partner laboratories and health basket programs.
- Point-of-Care Rapid Tests: Supplies rapid diagnostic tests for coronavirus, pregnancy, influenza, streptococcus, occult blood, Helicobacter pylori, and drug testing to hospitals, Ministry of Health, HMOs, and private laboratories.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | MyScreen Extended Carrier Screening - Health Basket |
| Subscription | One time/ perpetual license | MyScreen Full Panel (Private Testing) |
| Usage-based | Pay-as-you-go | Central Laboratory Diagnostics |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Gamidor Diagnostics product offering
Product offeringCore offering
Gamidor Diagnostics is the exclusive Israeli distributor for multiple world-leading medical diagnostic manufacturers, supplying diagnostic systems, reagents, and testing services to clinical laboratories, hospitals, HMOs, academic research institutes, and the general public. The portfolio spans genetic screening (including the proprietary MyScreen NGS-based carrier screening and GeneFax AI genetic counseling), allergy and autoimmune testing, central laboratory diagnostics, tissue diagnostics, point-of-care testing, rapid tests, molecular biology, and life science automation.
Product overview
Gamidor Diagnostics is a medical diagnostic distributor that markets systems, reagents, and services to clinical laboratories, hospitals, health maintenance organizations, research institutes, and the general public in Israel. The company represents world-leading diagnostic manufacturers exclusively. The product portfolio consists of multiple distinct platforms and sub-brands organized across diagnostic categories: Genetic Screening (MyScreen NGS carrier screening, AutoDelfia prenatal screening, Vanadis NIPT, NanoChip microarray, Saphyr optical genome mapping, NanoChip OncoPanel 51); Allergy & Autoimmunity (Phadia Laboratory Systems with ImmunoCAP and EliA tests); Central Laboratory (Snibe CLIA analyzers); Tissue Diagnostics (VENTANA/Roche automation); Point of Care (HemoScreen hematology, rapid tests, NanoDx TBI); Women's Health (PAP cytology, HPV molecular testing with Evalyn Brush); Molecular Biology (Real-Time PCR, NGS, nucleic acid isolation); Quality Control (CAP, Randox); and Life Science automation (Tecan, Liconic, Peak Robotics). GeneFax AI software, developed in partnership with Optra Health, provides genetic counseling chatbot functionality. The company does not manufacture its own diagnostic products but distributes and supports international brands exclusively in Israel.
Differentiator
Problem solved
Functional benefit
Brands
- MyScreen: Extended genetic carrier screening test covering over 500 genetic diseases using NGS technology
- GeneFax
Products and services
- MyScreen Extended carrier genetic screening test based on NGS technology that simultaneously screens for over 500 genetic diseases and 1,900+ mutations common across all Israeli populations, developed and marketed exclusively by Gamidor Diagnostics.
- GeneFax AI-powered genetic counseling chatbot software developed in partnership with Optra Health that provides interactive pre-test and post-test genetic counseling through mobile app or dedicated website using natural language dialogue.
- AutoDelfia (Prenatal Screening) Automated immunoassay platform for first and second trimester prenatal screening including PAPP-A, fBHCG, AFP, HCG, UE3, and Inhibin tests, with risk calculation using Life Cycle software.
- Vanadis NIPT Non-Invasive Prenatal Testing system for detection of trisomies 13, 18, 21 and sex chromosome abnormalities directly from maternal blood using automated analysis without DNA sequencing, distributed through Revvity.
- NanoChip Automated Microarray System Automated microarray system for genetic carrier screening used in Israeli national screening programs for tests including CF, Tay-Sachs, Ashkenazi Panel, BRCA, and more.
- Phadia Laboratory Systems (ImmunoCAP) Automated blood test systems for allergy, asthma, and autoimmune disease diagnosis, ranging from Phadia 200 to Phadia 5000 throughput systems, featuring ImmunoCAP specific IgE tests for 600+ allergens and EliA autoimmune tests.
- Snibe Analyzers (Central Laboratory Diagnostics) Central laboratory diagnostic analyzers performing chemiluminescence immunoassay (CLIA) testing across 50+ hospitals, central laboratories, and clinics in Israel, providing hundreds of laboratory results per minute.
- HemoScreen Point-of-care hematology device by Pixcell Medical for 5-part CBC testing, FDA-cleared for POC use, using disposable cartridges with all reagents pre-included, requiring no maintenance or calibration.
- NanoDx (TBI) Nanosensor diagnostic test system for traumatic brain injury (TBI) providing rapid, definitive assessment to reduce misdiagnosis, distributed by Gamidor through NanoDiagnostics.
- Saphyr System (Optical Genome Mapping) Optical Genome Mapping system by Bionano Genomics for detection of structural variants in DNA including translocations, deletions, duplications, used in hematology/oncology diagnostics and genetic disease testing.
- VENTANA (Roche) Tissue Diagnostics Automated slide-staining instruments for Immunohistochemical (IHC), molecular ISH testing, and Histochemical staining in tissue pathology diagnostics.
- Evalyn Brush Self-sampling HPV test brush by Rovers Medical Devices for cervical cancer screening, enabling women to collect samples at home for laboratory HPV testing, used in Maccabi HMO pilot.
- Rapid Tests (Point-of-Care) Point-of-care rapid diagnostic tests including COVID-19 antigen/antibody tests, pregnancy tests, influenza, streptococcus, fecal occult blood, H. pylori, drug screening, and alcohol tests, supplied to the Ministry of Health, hospitals, HMOs, and private laboratories.
- Quality Control Solutions (CAP & Randox) External and internal quality control solutions including CAP (College of American Pathologists) proficiency testing and Randox Acusera true third-party internal quality controls for laboratory analytics.
- Tecan Laboratory Automation Tecan liquid handling automation, Liconic sample storage, Peak Robotics, and customized automation solutions for research, drug discovery, and biotech applications.
Quantifiable outcome
- Tests performed in 50+ hospitals and central laboratories across Israel
- +3 more outcomes
Companies that use Gamidor Diagnostics
Customer profileNamed customers8 records
Segments6 records
Ideal customer profiles4 records
Gamidor Diagnostics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature4 records
Gamidor Diagnostics partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and minor.
- TecancoreStarting July 1, 2023, Gamidor Diagnostics became the sole distributor for Tecan products in Israel. Provides full technical and application support through a skilled professional team. Ensures continuous transfer of representation and continuation of high-quality service.
- Thermo Scientific (Phadia Laboratory Systems)coreExclusive representative for Phadia Laboratory Systems allergy and autoimmune testing. Includes ImmunoCAP specific IgE tests (600+ allergens), EliA autoimmune tests (57 tests), and ISAC multiplex testing. Partnership spans over 20 years.
- RevvitycoreExclusive representative for Revvity prenatal screening, neonatal screening, and reproductive health products since 1984. Includes AutoDelfia systems, Vanadis NIPT, PIGF tests for pre-eclampsia screening, and prenatal biochemical screening.
- Pixcell MedicalminorDistribution of HemoScreen device for point-of-care hematology testing. Only FDA-cleared 5-part CBC POC device.
- NanoDiagnosticsminorDistribution of NanoDx device for traumatic brain injury (TBI) diagnostic testing.
- Rovers Medical DevicesminorExclusive representation of Evalyn brush for HPV self-sampling. Used in Maccabi HMO pilot for cervical cancer screening.
- Savyon DiagnosticscoreCo-developer of GeneFax AI genetic counseling software and manufacturer/supplier of NanoChip automated microarray systems for Israeli carrier screening program.
- Optra HealthminorPartnership for GeneFax AI genetic counseling software launch in Israel. Software used by major US healthcare providers including Lab Corp, Quest Diagnostics, and Baylor Genetics.
- Bionano GenomicsminorDistribution of Saphyr system for Optical Genome Mapping (OGM) to detect structural variants in DNA for hematology-oncology and genetic disease diagnosis.
- SnibecoreDistribution of Snibe analyzers for central laboratory diagnostics. Systems deployed in 50+ hospitals and clinics across Israel performing tens of millions of tests annually.
- VENTANA (Roche)coreSpecialized in immunohistochemical (IHC) testing, molecular ISH testing, and histochemical staining on automated slide-staining instruments from VENTANA.
- PerkinElmercoreDistribution of Vanadis NIPT system for non-invasive prenatal testing. Enables Israeli laboratories to perform NIPT testing locally without sending samples abroad.
Scale indicators5 records
Recent moves7 records
Expansion highlights4 records
Gamidor Diagnostics competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key highlights6 records
Customer concentration
Gamidor Diagnostics social profiles
Digital presenceGamidor Diagnostics compliance and trust
Trust signalCompliance4 records
Gamidor Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Gamidor Diagnostics leadership team
Management profileNumber of profiles
Profiles10 records
Gamidor Diagnostics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Gamidor Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Gamidor Diagnostics
What does Gamidor Diagnostics do?
Gamidor Diagnostics is the exclusive Israeli distributor for multiple world-leading medical diagnostic manufacturers, supplying diagnostic systems, reagents, and testing services to clinical laboratories, hospitals, HMOs, academic research institutes, and the general public. The portfolio spans genetic screening (including the proprietary MyScreen NGS-based carrier screening and GeneFax AI genetic counseling), allergy and autoimmune testing, central laboratory diagnostics, tissue diagnostics, point-of-care testing, rapid tests, molecular biology, and life science automation.
Is Gamidor Diagnostics a public or private company?
Gamidor Diagnostics is a private company. It is classified as corporate owned and is currently operating.
When was Gamidor Diagnostics founded?
Gamidor Diagnostics was founded in 1984. It employs 101 to 250 people.
Where is Gamidor Diagnostics based?
Gamidor Diagnostics is headquartered in Petah Tiqwa, Israel, in the Middle East region.
How does Gamidor Diagnostics make money?
Three revenue lines are on record. Diagnostic Systems and Reagents Distribution is the primary driver. The others are genetic Testing Services and point-of-Care Rapid Tests.
Does Gamidor Diagnostics have an API?
No public API is recorded for Gamidor Diagnostics.
What industry is Gamidor Diagnostics in?
Gamidor Diagnostics's product category is In-Vitro Diagnostics Distribution. Its primary akta.pro industry code is HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics), with a secondary code of HLAAALAJ, Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening). Its NAICS code is 6215 and its SIC code is 8071.